Soluble circulating cytokine receptors in chronic inflammatory lung diseases
Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.
Europe deserves more and better research & innovation in cardiovascular disease
Prof Lina Badimon, Chair, ESC Advocacy Committee 2018-2020 Director, Cardiovascular Program (ICCC) – IR, Hospital de la Santa Crue I Sant Pau, argues that Europe deserves more and better research & innovation in cardiovascular disease.
A focus on rare disease: Paroxysmal nocturnal haemoglobinuria (PNH)
Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.
Leading a normal life with a Noonan Syndrome child: Benji Ballard’s story
Katie Ballard, a trustee of the Noonan Syndrome Association, shares her story of son Benjamin after receiving a life-changing diagnosis of Noonan Syndrome and cardiomyopathy.
Pulmonary rehabilitation: Changing the lives of patients with lung disease
Jessica Eagelton, co-chair of the Taskforce for lung Health Pulmonary Rehabilitation working group, discusses Pulmonary rehabilitation: a drug-free treatment that is changing the lives of people with lung disease.
European Commission announces €232 million aid package to tackle COVID-19
In a bid to tackle the recent outbreak of COVID-19 the European Commission has announced a new aid package worth €232 million.
Global Food Research: Will front-of-the-package warning labels change our eating habits?
The Global Food Research Program shares their perspective on targeting ultra-processed foods with front-of-the-package warning labels, which is the only impactful approach.
The 2010s: Advances witnessed in muscle-wasting conditions research
Kate Adcock, Director of Research and Innovation, Muscular Dystrophy UK, charts the advances over the past decade in muscle-wasting conditions research.
Assessment and surveillance to mitigate infectious diseases in Africa
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, gives a call to action when it comes to assessment and surveillance to mitigate the impact of infectious diseases in Africa.
Lung disease: A focus on idiopathic pulmonary fibrosis
Stephen C Clark, from Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Northumbria in the UK explains idiopathic pulmonary fibrosis, a type of lung disease.
Government pledges £20 million to develop new coronavirus vaccine
The Government has today pledged £20 million to develop a new coronavirus vaccine following concerns over the ongoing outbreak in China.
Multiple cases of coronavirus confirmed in the UK
Chief Medical Officer, Professor Chris Whitty has announced that two cases of coronavirus have been confirmed in England.
Controlling and preventing diseases: A focus on traumatic brain injury
The work of the Centers for Disease Control and Prevention, within the U.S. Department of Health & Human Services is examined here, with a special focus on traumatic brain injury.
Fine dust air pollution (PM2.5) as a cause of chronic inflammatory lung diseases?
Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.
Environmental exposures during early life influence adult disease risk
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Living with Chronic Obstructive Pulmonary Diseases (COPD)
More can be done at the local, national and EU level to improve COPD diagnosis, support smoking cessation and advance work and living conditions for people living with COPD.
Cardiovascular disease: A leading cause of disability and premature death
Dr Tejas Patel, a world-renowned interventional cardiologist and endovascular therapist, highlights cardiovascular disease, a leading cause of disability and premature death around the world.
Researchers discover new genetic brain disease
Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.
The Japanese Society of Nephrology: Research and education to tackle kidney disease
Here we find out how The Japanese Society of Nephrology engages in research developing human resources, providing lifelong education and disseminating knowledge to the public, to tackle kidney disease and promote health.
Idiopathic pulmonary fibrosis: An incurable lung disease
Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease.